Articles & Video
Decentralized and Hybrid Clinical Trials Report 2020
Our Decentralized and Hybrid Clinical Trials Report looks at how the industry is adopting virtual trials, as well as challenges that need to be overcome.
Clinical Trials Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in clinical trials with one simple registration.
The Pain Clinic 2019
At Clinical Trials Europe, Kate O’Brien held The Pain Clinic. In this interactive eBook, she looks at the key takeaways from the week.
CRO oversight: 6 things to consider when selecting a vendor
What must a clinical trial sponsor look for in choosing a CRO? Here's a checklist of 6 important things.
The Pain Clinic with Kate O'Brien
Discover the most common issues facing clinical trials, and potential solutions in this interactive flipbook from site consultant Kate O'Brien.
Real World Evidence in clinical trials: 3 case studies of successful implementation
Using Real World Evidence in clinical trials has huge potential, but also faces many hurdles - we look at 3 successful case studies.
11 ways clinical trial protocol design can improve speed and costs
We look at 11 different opportunities to improve speed and cost of clinical trials by taking into consideration both protocol designs and contextual variables such as collaborations.
A clinical trial investigator's insider view
Site consultant Kate O’Brien speaks to two clinical trial investigators and a research nurse about the challenges facing sites today.
3 case studies for implementing wearables in clinical trials
We look at three case studies of how wearables are being used in clinical trials and try to separate reality from hype.
10 predictions for clinical trials in 2020 - INDUSTRY VOICES
We asked 10 clinical trial insiders their predictions for how clinical trials will most change in 2020.
How can the success of clinical partnerships be measured? - INDUSTRY VOICES
We asked five industry experts which metrics can be measured to judge the success of clinical partnerships.
How close are we to fully virtual oncology clinical trials?
What steps still need to be taken to implement virtual clinical trials in oncology?
How clinical trial Principal Investigators can maintain oversight
How can Principal Investigators maintain clinical trial oversight and delegate staff roles? Site consultant Kate O’Brien offers some advice.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
The operational challenges facing virtual clinical trials - INDUSTRY VOICES
Virtual clinical trials face a number of operational challenges before they can be fully and effectively implemented. We ask five industry insiders about how to overcome them.
Outsourcing in clinical trials: an EU struggle? - Data report analysis
In a recent report, we investigated what today’s clinical trials professionals see as the biggest risks faced in managing relationships with third-party organisations.
Transforming protocol deviation and management with TransCelerate
How the TransCelerate Protocol Deviations Initiative is helping guide sites and sponsors on the ICH E3 guideline.
Making the patient's life as easy as possible
Site consultant Kate O’Brien looks at how the lives of patients in clinical trials can be made easier in clinical trials to improve retention.
Clinical Trials State of the Industry Report 2019
Clinical Trials State of the Industry 2019: Download the report offering insights into wearables, AI, virtual trials, partnerships and vendor oversight.
How sites and sponsors can support patients in clinical trials
How can sites and Sponsors support patients during trials to improve engagement and retention? Site consultant Kate O'Brien explores.
Innovative protocol designs in early phase clinical development - WHITEPAPER
This whitepaper reviews innovative trends in protocol designs in early phase clinical development and digitalization, as well key regulatory opportunities and challenges.